10 August 2016

VERONA PHARMA PLC - Notice of Results

PR Newswire

Read more

9 August 2016

Director Dealing

 

Read more

6 August 2016

VERONA PHARMA PLC - Grant of Share Options

PR Newswire

Read more

5 August 2016

Holding(s) in Company

 

Read more

4 August 2016

Holding(s) in Company

 

Read more

3 August 2016

Holding(s) in Company

 

Read more

3 August 2016

Holding(s) in Company

 

Read more

3 August 2016

Holding(s) in Company

 

Read more

2 August 2016

Holding(s) in Company

 

Read more

2 August 2016

Holding(s) in Company - Replacement

The following announcement replaces the notification Ref 9994F issued on 2 August 2016. The amendment is to Section 9 which should read as follows: The voting rights are managed and controlled by Edmond de Rothschild Investment Partners, acting in its capacity of manage…

Read more

Innovative Therapies for Respiratory Care

See the 2017 Verona Pharma corporate video 2017

Runtime: 04:05

Go

The Lancet Respiratory Medicine

Peer-reviewed paper in the Lancet's highly-respected medication journal

Basic & Clinical Pharmacology & Toxicology

Peer-reviewed publication on dual PDE3/4 inhibitors as novel treatments for COPD

Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us